Board of Directors

Gary E. Costley Ph.D.
Lead Director
Managing Partner at C&G Capital and Management, a private investment company, since 2004. He previously served from 2001 to 2004 as chairman and chief executive officer of International Multifoods Corporation and from 1997 to 2001 as its chairman, president and chief executive officer. Dr. Costley is currently a director of Principal Financial Group and Accelrys, Inc.
  • Audit Committee
  • Compensation Committee
  • Nominating and Corporate Governance Committee
John E. Byom
Chairman - Audit Committee; Financial Expert
John E. Byom brings broad financial strategic and operating experience to Prestige Brands Holdings, Inc. His background includes high level positions at The J.M. Smucker Company and International Multifoods Corporation, two consumer products companies listed on the New York Stock Exchange. Mr. Byom is a graduate of Luther College in Decorah, Iowa. He is a member of the Board of Directors of MGP Ingredients and chairs their Audit Committee.
  • Audit Committee 
  • Compensation Committee Chair
  • Nominating and Corporate Governance Committee
Christopher J. Coughlin
Mr. Coughlin was appointed to the board in July, 2019.  Previously Mr. Coughlin served as Senior Advisor to the CEO and Board of Directors of Tyco International, Ltd., a diversified holding company, from 2010 until 2012. Prior to that, he was Executive Vice President and Chief Financial Officer of Tyco International from 2005 to 2010. Prior to joining Tyco, he worked in the Chief Operating Officer and Chief Financial Officer roles of the Interpublic Group of Companies as well as Executive Vice President and Chief Financial Officer role of Pharmacia Corporation from 1998 until its acquisition by Pfizer in 2003.

Mr. Coughlin earned a bachelor’s degree in Accounting from Boston College. Mr. Coughlin has since 2014 served on the boards of Allergan plc and Alexion Pharmaceuticals, Inc. and has been the Lead Independent Director of Allergan since October 2016. He previously served on the boards of The Dun & Bradstreet Corp, Hologic, Inc., Covidien Ltd, Dipexium Pharmaceuticals, Inc., Forest Laboratories, Inc., Interpublic Group of Companies, Monsanto Company and Perrigo Company.
  • Nominating and Corporate Governance Committee
  • Audit Committee Chair
  • Compensation Committee
Sheila A. Hopkins
Sheila A. Hopkins was named a director in August 2015. Ms. Hopkins served as Executive Vice President and President, Global Vision Care for Bausch + Lomb, a healthcare company, from September 2011 until her retirement in August 2013. Prior to that, she spent 14 years at Colgate-Palmolive, a consumer products company, where she held several senior management positions including Vice President and General Manager, Personal Care, and Vice President, Global Business Development from September 1997 to August 2011. She has also held marketing and sales positions at Procter & Gamble, American Cyanamid and Tambrands. Ms. Hopkins earned a B.A. in History from Wellesley College. She served on the Board of Directors of Warnaco Inc., a leading apparel company, from 2003 to 2013, and on the Board of the Consumer Healthcare Products Association (CHPA).
  • Audit Committee
  • Compensation Committee
  • Nominating and Governance Committee
James M. Jenness
Chairman - Compensation Committee; Chairman - Nominating and Corporate Governance Committee
James M. Jenness was appointed to the board in May, 2015. Mr. Jenness is the retired Chairman of the Board and CEO of the Kellogg Company, a producer of cereal and convenience foods. He served as Kellogg’s Chairman from February 2005 to June 2014, and as CEO from 2004-2006. He has served as a director of Kellogg since 2007 and as a director of Kimberly-Clark Corporation, a producer of personal care products, since 2007. Mr. Jenness’ background also includes serving as Chief Executive Officer of Integrated Merchandising Systems, LLC, a retail promotion and merchandising company, and a 22 year career with Leo Burnett Company, Inc., the global advertising agency, where he last served as Vice Chairman and Chief Operating Officer.
  • Audit Committee
  • Compensation Committee
  • Nominating and Governance Committee Chair
Ron Lombardi
Chairman of the Board, President & CEO
Ron Lombardi was named President and CEO on June 1, 2015 after serving as Chief Financial Officer since 2010. He was subsequently elected Chairman of the Board in May 2017. He brings extensive financial management experience to the position, with expertise in acquisitions and divestitures, debt and equity structuring, and building financial infrastructure. He served as CFO for Waterbury International Holdings, a private equity-owned firm. Prior to that, he was with the Cannondale Sports Group/Dorel Recreation and Leisure, a consumer sporting equipment and apparel company, in positions of increasing financial responsibility, beginning as CFO and then as Chief Operating Officer. Also included in his background are leadership positions in finance at Gerber Scientific and Emerson Electric, two large publicly traded companies.

Ron holds a B.S from Springfield College, received an MBA at American International College and is a Certified Public Accountant.
Natale S. Ricciardi
Natale S. Ricciardi , Retired President, Pfizer Global Manufacturing and Senior Vice President of Pfizer Inc., was elected to the Board of Directors on May 26, 2016. Mr. Ricciardi spent his entire 39 year career at Pfizer Inc., a biopharmaceutical company, until his retirement in 2011. He was responsible for all of Pfizer’s internal and external supply organization, a global enterprise that grew to more than 100 manufacturing facilities. He earned a degree in Chemical Engineering from The City College of New York and an MBA in Finance and International Business from Fordham University.

  • Audit Committee
  • Nominating Committee
  • Compensation Committee

Primary IR Contact
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819

Transfer Agent

6201 15th Avenue
Brooklyn, NY 11219
Telephone: (800) 937-5449


Stay up to date with investor news, stock information and SEC filings.
Subscribe »